Nirjal Bhattarai

674 total citations
22 papers, 508 citations indexed

About

Nirjal Bhattarai is a scholar working on Immunology, Hepatology and Epidemiology. According to data from OpenAlex, Nirjal Bhattarai has authored 22 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 10 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Nirjal Bhattarai's work include Hepatitis C virus research (10 papers), Immune Cell Function and Interaction (9 papers) and HIV Research and Treatment (6 papers). Nirjal Bhattarai is often cited by papers focused on Hepatitis C virus research (10 papers), Immune Cell Function and Interaction (9 papers) and HIV Research and Treatment (6 papers). Nirjal Bhattarai collaborates with scholars based in United States. Nirjal Bhattarai's co-authors include Jack T. Stapleton, Joseph W. Fischer, Jinhua Xiang, James H. McLinden, Ernest T. Chivero, Alan N. Baer, Thomas M. Kaufman, Mark A. Winters, Mark Holodniy and Alan Landay and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Scientific Reports.

In The Last Decade

Nirjal Bhattarai

21 papers receiving 505 citations

Peers

Nirjal Bhattarai

HEPAT

EPIDE

VIROL

IMMUN

Sharon E. Hopcraft United States

Bridget M. Donovan United States

Aryn A. Price United States

Isabel Gallego Spain

Gaia Trincucci Switzerland

Tingting Pan China

Sangeetha Vijaysri United States

Kirsten K. Dietze Germany

Raphaële Germi France

Mayra Cruz‐Rivera Mexico

Sharon E. Hopcraft United States

Nirjal Bhattarai

297 ×1.7

HEPAT

321 ×2.1

EPIDE

74 ×0.5

VIROL

87 ×0.7

IMMUN

95 ×0.8

Citations per year, relative to Nirjal Bhattarai Nirjal Bhattarai (= 1×) peers Sharon E. Hopcraft

Countries citing papers authored by Nirjal Bhattarai

Since Specialization

Citations

This map shows the geographic impact of Nirjal Bhattarai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nirjal Bhattarai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nirjal Bhattarai more than expected).

Fields of papers citing papers by Nirjal Bhattarai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nirjal Bhattarai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nirjal Bhattarai. The network helps show where Nirjal Bhattarai may publish in the future.

Co-authorship network of co-authors of Nirjal Bhattarai

This figure shows the co-authorship network connecting the top 25 collaborators of Nirjal Bhattarai. A scholar is included among the top collaborators of Nirjal Bhattarai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nirjal Bhattarai. Nirjal Bhattarai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiang, Jinhua, James H. McLinden, Qing Chang, et al.. (2025). Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition. The Journal of Infectious Diseases. 232(5). 1228–1238.

Baer, Alan N., et al.. (2025). Feeder cell-free production of CAR-NK cells via activation of PKC and calcium signaling pathways. Cytotherapy. 27(8). 1013–1022. 1 indexed citations

Bhattarai, Nirjal, et al.. (2025). A Scalable Protocol for Ex Vivo Production of CAR-Engineered Human NK Cells. Methods and Protocols. 8(5). 102–102. 2 indexed citations

Baer, Alan N., et al.. (2024). Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation. Frontiers in Immunology. 15. 1519415–1519415. 2 indexed citations

Xiang, Jinhua, et al.. (2023). Characterization of “Off-Target” Immune Modulation Induced by Live Attenuated Yellow Fever Vaccine. The Journal of Infectious Diseases. 229(3). 786–794. 4 indexed citations

Baer, Alan N., et al.. (2021). A short hepatitis C virus NS5A peptide expression by AAV vector modulates human T cell activation and reduces vector immunogenicity. Gene Therapy. 29(10-11). 616–623. 1 indexed citations

Baer, Alan N., et al.. (2021). TCR-independent Activation in Presence of a Src-family Kinase Inhibitor Improves CAR-T Cell Product Attributes. Journal of Immunotherapy. 45(3). 139–149. 4 indexed citations

Fischer, Joseph W. & Nirjal Bhattarai. (2021). CAR-T Cell Therapy: Mechanism, Management, and Mitigation of Inflammatory Toxicities. Frontiers in Immunology. 12. 693016–693016. 70 indexed citations

Baer, Alan N., et al.. (2018). Characterization of the effects of immunomodulatory drug fingolimod (FTY720) on human T cell receptor signaling pathways. Scientific Reports. 8(1). 10910–10910. 45 indexed citations

10.

Baer, Alan N., et al.. (2017). Src-family kinases negatively regulate NFAT signaling in resting human T cells. PLoS ONE. 12(10). e0187123–e0187123. 13 indexed citations

11.

Bhattarai, Nirjal, James H. McLinden, Jinhua Xiang, et al.. (2017). Hepatitis C virus infection inhibits a Src-kinase regulatory phosphatase and reduces T cell activation in vivo. PLoS Pathogens. 13(2). e1006232–e1006232. 11 indexed citations

12.

Chivero, Ernest T., Nirjal Bhattarai, James H. McLinden, Jinhua Xiang, & Jack T. Stapleton. (2015). Human Pegivirus (HPgV; formerly known as GBV-C) inhibits IL-12 dependent natural killer cell function. Virology. 485. 116–127. 16 indexed citations

13.

Bhattarai, Nirjal, James H. McLinden, Jinhua Xiang, Thomas M. Kaufman, & Jack T. Stapleton. (2015). Conserved Motifs within Hepatitis C Virus Envelope (E2) RNA and Protein Independently Inhibit T Cell Activation. PLoS Pathogens. 11(9). e1005183–e1005183. 25 indexed citations

14.

Stapleton, Jack T., Jinhua Xiang, James H. McLinden, et al.. (2014). A novel T cell evasion mechanism in persistent RNA virus infection.. PubMed. 125. 14–24; discussion 24. 10 indexed citations

15.

Bhattarai, Nirjal, James H. McLinden, Jinhua Xiang, et al.. (2013). GB Virus C Particles Inhibit T Cell Activation via Envelope E2 Protein-Mediated Inhibition of TCR Signaling. The Journal of Immunology. 190(12). 6351–6359. 33 indexed citations

16.

McLinden, James H., Jack T. Stapleton, Donna Klinzman, et al.. (2013). Chimpanzee GB virus C and GB virus A E2 envelope glycoproteins contain a peptide motif that inhibits human immunodeficiency virus type 1 replication in human CD4+ T-cells. Journal of General Virology. 94(4). 774–782. 2 indexed citations

17.

Xiang, Jinhua, James H. McLinden, Thomas M. Kaufman, et al.. (2012). Characterization of a peptide domain within the GB virus C envelope glycoprotein (E2) that inhibits HIV replication. Virology. 430(1). 53–62. 19 indexed citations

18.

Bhattarai, Nirjal & Jack T. Stapleton. (2012). GB virus C: the good boy virus?. Trends in Microbiology. 20(3). 124–130. 117 indexed citations

19.

Bhattarai, Nirjal, James H. McLinden, Jinhua Xiang, Thomas M. Kaufman, & Jack T. Stapleton. (2012). GB Virus C Envelope Protein E2 Inhibits TCR-Induced IL-2 Production and Alters IL-2–Signaling Pathways. The Journal of Immunology. 189(5). 2211–2216. 27 indexed citations

20.

Bhattarai, Nirjal, et al.. (2012). Gb Virus C Infection is Associated with a Reduced Rate of Reactivation of Latent HIV and Protection against Activation-Induced T-Cell Death. Antiviral Therapy. 17(7). 1271–1279. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact